FDA enforcement actions plummet under Trump
From monitoring clinical trials and approving medicines and vaccines, to ensuring the safety of blood transfusions, medical devices, groceries, and more, the U.S. Food and Drug Administration (FDA) is one of the nations most vital watchdogs. By several measures, however, FDAs compliance and enforcement actions have plummeted since President Donald Trump took office, Science has found.
The agencys warning lettersa key tool for keeping dangerous or ineffective drugs and devices and tainted foods off the markethave fallen by one-third, for example. Such letters typically demand swift corrections to protect public health and safety. FDA records from Trumps inauguration through 22 May show the agency issued 1033 warning letters, compared with 1532 for the most recent equivalent period under former President Barack Obama. Compared with the start of the Obama presidency, Trump-era letters dropped by nearly half.
Warnings from the FDA Center for Devices and Radiological Health, which helps ensure the safety and quality of medical devices, and from some of the agencys district officesincluding Philadelphia, Florida, and New Yorkhave dropped even more steeply, by more than two-thirds. Two district offices have not issued a warning in more than 2 years. The numbers dont just reflect a new administrations slow start. FDA sent significantly fewer warning letters in the second year of Trumps presidency than in his first.
FDA watchers say they cant pinpoint whats driving the decline, but they are alarmed. Those who think the Trump administration has not succeeded in its deregulatory efforts ought to look at these data, says Peter Lurie, an FDA executive under Obama and Trump and now executive director of the Center for Science in the Public Interest, a Washington, D.C., advocacy group. Industry may well take the message from this that the cop is not on the beat as often.
-more-
https://www.sciencemag.org/news/2019/07/exclusive-fda-enforcement-actions-plummet-under-trump